IQVIA Holdings stock was EUR 237.30 on October 16, 2026, 1.82 percent below high

Published on 10/17/2026 at 19:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The high was EUR 241.70 on September 24, 2026. IQVIA Holdings stock costs EUR 237.30 on October 16, 2026, down 1.41 percent versus Frankfurt close.

Stock sits below yearly high

Frankfurt trading left IQVIA Holdings 1.82 percent below its high on October 16, 2026.
IQVIA carried a P/E ratio of 33.11 on October 16, 2026.
IQVIA Holdings stock costs EUR 237.30 at Frankfurt on October 16, 2026 at 9:55 p.m. CEST, down 1.41 percent versus the Frankfurt close of October 15, 2026.
IQVIA is scheduled to report third-quarter results on October 27, 2026.

Architektur-CGI eines modernen Glashochhauses für Gesundheitsdatenanalytik mit Wasserplatz — IQVIA Holdings Konzernzentrale US46266C1053 als moderner Architektur Render mit Glasfassade und spiegelndem Wasserbecken davor, Illustration mit AI erstellt.

IQVIA Holdings stock stood 1.82 percent below its 52-week high of EUR 241.70 on October 16, 2026, according to the Frankfurt quotation. The distance keeps the stock close to its recent peak, while the latest session ended below the previous Frankfurt close.

IQVIA Holdings was quoted at EUR 237.30 in Frankfurt on October 16, 2026 at 9:55 p.m. CEST, down 1.41 percent versus the Frankfurt close of October 15, 2026 at EUR 240.70. The day range ran from EUR 235.20 to EUR 241.10, placing the final quote EUR 4.40 below the session high.

Price position near the yearly high

The 52-week range was EUR 134.20 to EUR 241.70 as of October 16, 2026. The high was reached on September 24, 2026, while the low was recorded on April 29, 2026. IQVIA stock gained 23.50 percent year to date, according to the Frankfurt market overview, and rose 2.40 percent over the latest week.

Valuation and reporting date

IQVIA had a market capitalization of USD 43.9 billion and a P/E ratio of 33.11 as of October 16, 2026. Its primary listing is the NYSE under ticker IQV, as identified in IQVIA's investor release.

IQVIA is scheduled to announce its third-quarter 2026 results before the NYSE opens on October 27, 2026, with a conference call at 9:00 a.m. Eastern Time, according to IQVIA.

Comparison with peers

IQVIA Holdings: minus 1.41 percent, P/E 33.11, market capitalization USD 43.9 billion.

Medpace (Nasdaq, USD): minus 1.61 percent, P/E 36.23, market capitalization USD 17.3 billion.

Charles River Laboratories (NYSE, USD): minus 1.99 percent, negative P/E 61.89, market capitalization USD 14.5 billion.

What the price position shows

IQVIA's current euro quotation is close to its 52-week high, but the latest Frankfurt session still finished 1.41 percent below its prior close. The combination of a 33.11 P/E ratio and a USD 43.9 billion market value gives the upcoming October 27 results a clear calendar role for the stock.

IQVIA Holdings was at EUR 237.30 in Frankfurt on October 16, 2026 at 9:55 p.m. CEST, down 1.41 percent versus the Frankfurt close of October 15, 2026 at EUR 240.70. The further course of trading is shown by the continuously updated real-time quote of IQVIA Holdings stock.